Last reviewed · How we verify
Allogenic Islet Cell Transplantation
Allogenic Islet Cell Transplantation is a Biologic drug developed by Kenneth Brayman, MD. It is currently in Phase 1 development.
At a glance
| Generic name | Allogenic Islet Cell Transplantation |
|---|---|
| Sponsor | Kenneth Brayman, MD |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Type 1 Diabetes (PHASE1, PHASE2)
- Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes (PHASE1, PHASE2)
- Islet Transplantation in Patients With "Brittle" Type I Diabetes (NA)
- Islet Transplantation in Type 1 Diabetic Kidney Allograft (PHASE2)
- Allogenic Islet Cell Transplantation (PHASE1, PHASE2)
- Islet Cell Transplant for Type 1 Diabetes (PHASE2)
- Pancreatic Islet Transplantation to the Anterior Chamber of the Eye (NA)
- Allogeneic Islet Cells Transplanted Onto the Omentum (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Allogenic Islet Cell Transplantation CI brief — competitive landscape report
- Allogenic Islet Cell Transplantation updates RSS · CI watch RSS
- Kenneth Brayman, MD portfolio CI
Frequently asked questions about Allogenic Islet Cell Transplantation
What is Allogenic Islet Cell Transplantation?
Allogenic Islet Cell Transplantation is a Biologic drug developed by Kenneth Brayman, MD.
Who makes Allogenic Islet Cell Transplantation?
Allogenic Islet Cell Transplantation is developed by Kenneth Brayman, MD (see full Kenneth Brayman, MD pipeline at /company/kenneth-brayman-md).
What development phase is Allogenic Islet Cell Transplantation in?
Allogenic Islet Cell Transplantation is in Phase 1.